12:00 AM
 | 
Jan 04, 2010
 |  BC Week In Review  |  Company News  |  Deals

Applied NeuroSolutions, Eli Lilly deal

The companies expanded a 2006 deal to include an additional undisclosed target against Alzheimer's disease. Applied NeuroSolutions will receive an upfront payment of $750,000 for...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >